| Nome do produto |
Cefaparole |
| Sinônimos |
Cefaparole [USAN:INN]; (6R,7R)-7-((R)-2-Amino-2-(p-hydroxyphenyl)acetamido)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7beta(R*)))-; 7-(2-Amino-2-(p-hydroxyphenyl)acetamido)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-3-cephem-4-carboxylic acid; Cefaparol; Cefaparol [INN-Spanish]; Cefaparolum; Cefaparolum [INN-Latin]; Lilly 110264; (6R,7R)-7-{[amino(4-hydroxyphenyl)acetyl]amino}-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
| Fórmula molecular |
C19H19N5O5S3 |
| Peso Molecular |
493.5797 |
| InChI |
InChI=1/C19H19N5O5S3/c1-8-22-23-19(32-8)31-7-10-6-30-17-13(16(27)24(17)14(10)18(28)29)21-15(26)12(20)9-2-4-11(25)5-3-9/h2-5,12-13,17,25H,6-7,20H2,1H3,(H,21,26)(H,28,29)/t12-,13-,17-/m1/s1 |
| CAS Registry Number |
51627-20-4 |
| EINECS |
257-325-8 |
| Estrutura Molecular |
|
| Densidade |
1.688g/cm3 |
| índice de refração |
1.774 |
| Símbolos de perigo |
|
| Códigos de risco |
|
| Descrição da Segurança |
|
|
